Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
Rattachement africain : si. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: The Ki-67 proliferative index (PI) is part of the diagnosis of nodal B-cell lymphoma (nBCL), but its determination in cytological samples is not standardized. We aimed to establish an approach for the accurate determination of the Ki-67 PI in cytological slides to differentiate between indolent and aggressive nBCLs. METHODS: Patients diagnosed with nBCL by fine-needle aspiration biopsy and subsequent excision biopsy were included. Cell suspensions were prepared from biopsy samples for CD3/Ki-67 double immunocytochemical staining and flow-cytometric verification of lymphoma B-cell counts. The Ki-67 PI was assessed by manual counting and eyeballing in cytology and eyeballing in histology. The cut-off values for the differentiation between aggressive and indolent lymphomas were determined for each method. RESULTS: A strong correlation between manual and flow-cytometric counting of lymphoma B cells was confirmed (interclass correlation coefficient (IC coef.) = 0.78). The correlation of the Ki-67 PI determined in cytological and histological slides was also strong (IC coef. > 0.80). Histologically, 55 cases were classified as indolent and 31 as aggressive nBCLs. KI-67 PI cut-off values of 28.5%, 27.5%, and 35.5% were established for manual counting and eyeballing in cytology and eyeballing in histology, respectively, with high sensitivity and specificity. CONCLUSIONS: The Ki-67 PI, assessed by manual counting and eyeballing in cytological samples, accurately differentiates between indolent and aggressive nBCLs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas
- Date Crossref
- 23/07/2024
- Éditeur
- MDPI AG
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Institute of Oncology Ljubljana Department of Cytopathology pays non établi dans la noticeStructure de recherche
-
University of Ljubljana pays non établi dans la noticeUniversité ou école supérieure
-
University of Maribor pays non établi dans la noticeUniversité ou école supérieure
-
Faculty of Medicine pays non établi dans la noticeUniversité ou école supérieure
Department of Cytopathology — Institute of Oncology Ljubljana, University of Ljubljana et University of Maribor, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.